Recovery research fieldbook Evidence, not treatment advice
Recovery archive

Published recovery field note

PEG-MGF — Dosing, Side Effects & Research - PeptIQ

What is PEG-MGF? PEG-MGF (PEGylated mechano growth factor) is a polyethylene glycol-modified variant of the IGF-1 splice variant mechano growth factor (MGF), a local isoform of IGF-1 produced in muscles in response to mechanical loading or injury. PEGylation extends the half-life from minutes to approximately 5 days. Research demonstrates activation of muscle satellite cells and promotion of muscle hypertrophy and repair. Research only. Mechanism of Action IGF-1 receptor partial agonism via the MGF E-domain; activation and proliferation of muscle satellite (stem) cells (Pax7+); promotes local muscle repair, hypertrophy, and angiogenesis without the systemic IGF-1 metabolic effects Target: IGF-1 receptor (IGF1R), muscle satellite cells (Pax7+) Research Indications Tissue RepairMost Effective Demonstrated acceleration of wound healing and soft tissue repair in research Gut HealthEffective Research shows beneficial effects on intestinal lining and GI function Joint SupportEffective Associ

Context first

Study findings do not automatically establish clinical benefit, safety, dosing, or suitability for an individual.

What is PEG-MGF?

PEG-MGF (PEGylated mechano growth factor) is a polyethylene glycol-modified variant of the IGF-1 splice variant mechano growth factor (MGF), a local isoform of IGF-1 produced in muscles in response to mechanical loading or injury. PEGylation extends the half-life from minutes to approximately 5 days. Research demonstrates activation of muscle satellite cells and promotion of muscle hypertrophy and repair. Research only.

Mechanism of Action

IGF-1 receptor partial agonism via the MGF E-domain; activation and proliferation of muscle satellite (stem) cells (Pax7+); promotes local muscle repair, hypertrophy, and angiogenesis without the systemic IGF-1 metabolic effects

Target: IGF-1 receptor (IGF1R), muscle satellite cells (Pax7+)

Research Indications

Tissue RepairMost Effective

Demonstrated acceleration of wound healing and soft tissue repair in research

Gut HealthEffective

Research shows beneficial effects on intestinal lining and GI function

Joint SupportEffective

Associated with reduced joint inflammation and improved mobility

Muscle RecoveryModerate

May support faster recovery from muscle strains and exercise stress

Research Protocols

These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.

Goal Dose Frequency Route Starting Dose 100 mcg Once daily Subcutaneous injection Standard Dose 250 mcg Once daily Subcutaneous injection

Peptide & Drug Interactions

Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.

TB-500 / BPC-157 (stack)Compatible

NSAIDs (Ibuprofen, Naproxen)Caution

CorticosteroidsCaution

AnticoagulantsMonitor

GH SecretagoguesCompatible

NAD+Compatible

How to Reconstitute & Inject

Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.

1

Remove PEG-MGF vial from refrigeration and allow to reach room temperature (15–20 minutes) 2

Clean vial top with alcohol swab and allow to air dry completely 3

Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water) 4

Inject BAC water slowly down the side of the vial — do not aim directly at the powder 5

Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide 6

Allow 2–3 minutes for full dissolution — solution should be clear and colorless 7

Draw calculated dose into an insulin syringe for subcutaneous injection 8

Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy 9

Store reconstituted solution refrigerated (2–8°C) and use within 28 days

What to Expect

Week 1–2

Initial anti-inflammatory effects begin. Reduced pain and swelling in target area.

Week 2–4

Improved tissue mobility and reduced discomfort. Early healing acceleration.

Week 4–8

Significant recovery milestones. Stronger tissue repair and functional improvement.

Week 8–12

Near-complete healing in many cases. Improved strength and tissue integrity.

Side Effects & Safety

Generally well-tolerated in research settings Mild nausea with higher doses Injection site redness or discomfort Rare: Dizziness or lightheadedness Potential effect on blood pressure (monitor if hypertensive)

FDA Status & Regulatory Info

Research Only

PEG-MGF (PEGylated mechano growth factor) is a polyethylene glycol-modified variant of the IGF-1 splice variant mechano growth factor (MGF), a local isoform of IGF-1 produced in muscles in response to mechanical loading or injury. PEGylation extends the half-life from minutes to approximately 5 days. Research demonstrates activation of muscle satellite cells and promotion of muscle hypertrophy and repair. Research only.

Rx Required: No

503A Ban: No

Telehealth: N/AFull FDA Status Tracker

Community-reported data

The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.

Share Your Experience

Rate PEG-MGF in the PeptIQ app and help the community make informed decisions.

Research purposes only

This page is for educational reference. It is not medical or legal advice. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.

Connected topics

Follow this recovery question